Literature DB >> 32015992

Surgical metastasectomy for renal cell carcinoma: which patients are the real candidates for surgery?

Satoshi Kato1, Satoru Demura1, Hideki Murakami2, Hiroyuki Tsuchiya1.   

Abstract

Entities:  

Year:  2019        PMID： 32015992      PMCID： PMC6976505          DOI： 10.21037/atm.2019.11.139

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  25 in total

1.  Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma.

Authors:  Hans-Stefan Hofmann; Heinz Neef; Katharina Krohe; Petko Andreev; Rolf-Edgar Silber
Journal:  Eur Urol       Date:  2005-03-20       Impact factor: 20.096

2.  Outcomes Following Complete Surgical Metastasectomy for Patients with Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Harras B Zaid; William P Parker; Nida S Safdar; Boris Gershman; Patricia J Erwin; M Hassan Murad; Stephen A Boorjian; Brian A Costello; R Houston Thompson; Bradley C Leibovich
Journal:  J Urol       Date:  2016-07-26       Impact factor: 7.450

3.  Survival after complete surgical resection of multiple metastases from renal cell carcinoma.

Authors:  Angela L Alt; Stephen A Boorjian; Christine M Lohse; Brian A Costello; Bradley C Leibovich; Michael L Blute
Journal:  Cancer       Date:  2011-01-10       Impact factor: 6.860

4.  Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib.

Authors:  B Beuselinck; S Oudard; O Rixe; P Wolter; A Blesius; J Ayllon; R Elaidi; P Schöffski; E Barrascout; A Morel; B Escudier; H Lang; J Zucman-Rossi; J Medioni
Journal:  Ann Oncol       Date:  2010-10-11       Impact factor: 32.976

5.  Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based Assessment.

Authors:  Christian P Meyer; Maxine Sun; Jose A Karam; Jeffrey J Leow; Guillermo de Velasco; Sumanta K Pal; Steven L Chang; Quoc-Dien Trinh; Toni K Choueiri
Journal:  Eur Urol       Date:  2017-03-27       Impact factor: 20.096

6.  Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review.

Authors:  Idir Ouzaid; Umberto Capitanio; Michael Staehler; Christopher G Wood; Bradley C Leibovich; Börje Ljungberg; Hendrik Van Poppel; Karim Bensalah
Journal:  Eur Urol Oncol       Date:  2018-09-24

7.  Distribution of metastatic sites in renal cell carcinoma: a population-based analysis.

Authors:  M Bianchi; M Sun; C Jeldres; S F Shariat; Q-D Trinh; A Briganti; Z Tian; J Schmitges; M Graefen; P Perrotte; M Menon; F Montorsi; P I Karakiewicz
Journal:  Ann Oncol       Date:  2011-09-02       Impact factor: 32.976

8.  Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients.

Authors:  Emmanouil Fokas; Martin Henzel; Klaus Hamm; Gunnar Surber; Gabriele Kleinert; Rita Engenhart-Cabillic
Journal:  Strahlenther Onkol       Date:  2010-02-22       Impact factor: 3.621

9.  Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014.

Authors:  M Stenman; G Sinclair; P Paavola; P Wersäll; U Harmenberg; M Lindskog
Journal:  Radiother Oncol       Date:  2018-05-10       Impact factor: 6.280

10.  Spinal metastasectomy of renal cell carcinoma: A 16-year single center experience with a minimum 3-year follow-up.

Authors:  Satoshi Kato; Hideki Murakami; Satoru Demura; Koshi Nambu; Yoshiyasu Fujimaki; Katsuhito Yoshioka; Norio Kawahara; Katsuro Tomita; Hiroyuki Tsuchiya
Journal:  J Surg Oncol       Date:  2016-02-05       Impact factor: 3.454
View more
  1 in total

1.  Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?

Authors:  G Marvaso; G Corrao; O Oneta; M Pepa; M Zaffaroni; F Corso; S Gandini; A Cecconi; D Zerini; G C Mazzola; M Augugliaro; M Cossu Rocca; E Verri; F Cattani; F La Fauci; L Bergamaschi; S Luzzago; A F Mistretta; G Musi; F Nolè; O De Cobelli; R Orecchia; B A Jereczek-Fossa
Journal:  Clin Transl Oncol       Date:  2021-03-09       Impact factor: 3.405
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.